Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective study
Patients with hematologic malignancies suffer severe morbidity and mortality due to COVID-19 infection. LDH may serve as a risk factor associated with prognosis in the treatment of COVID-19. Monitoring variations in LDH levels can assist healthcare providers in evaluating disease progression, adjusting treatment plans in a timely manner, and predicting patient outcomes.
Authors
- Xiaojun Guan (ORCID: https://orcid.org/0000-0003-2313-4477)
- Fangkai He
- Wenjuan Di (ORCID: https://orcid.org/0000-0003-0799-3415)
- Yao Yao (ORCID: https://orcid.org/0000-0002-5809-2740)
- Bin Liu (ORCID: https://orcid.org/0000-0003-1691-8126)
- Depei Wu (ORCID: https://orcid.org/0000-0002-6312-3863)
- Xue Chen (ORCID: https://orcid.org/0000-0002-4441-9159)
- Ying Wang (ORCID: https://orcid.org/0000-0002-2571-9367)
- Zhou Huang (ORCID: https://orcid.org/0009-0009-5256-6042)
Institutions
- Soochow University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Suzhou Municipal Hospital (CN)
- Traditional Chinese Medicine Hospital of Kunshan (CN)
- First Affiliated Hospital of Soochow University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.3389/fonc.2024.1487516
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00